Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06269614 · ClinicalTrials.gov registry record · NA

Assessing the Gut Microbiome and Its Association With Pediatric Stress and Cognition

A NA study of Autism Spectrum Disorder and Adverse Childhood Experiences, sponsored by Nova Southeastern University.

Active
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT06269614 is a NA study of Autism Spectrum Disorder and Adverse Childhood Experiences that is active but no longer recruiting, run by Nova Southeastern University. The registered enrollment target is 75 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06269614, a NA study of Autism Spectrum Disorder and Adverse Childhood Experiences, is active but no longer recruiting, sponsored by Nova Southeastern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Using a metabolomics approach in combination with eye-tracking data, this research study proposes to gather evidence from two interrelated body systems (gut and brain) in order to assess how the microbiome is involved in stress modulated symptoms in children with autism and children exposed to repeated stress in comparison to a control group.

Interventions

  • DIETARY_SUPPLEMENT Probiotic

Study Locations (1)

Florida

  • Nova Southeastern University College of Nursing - Davie

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2023-01-12
Est. Completion 2027-12-31
Phase NA

Sponsor

Nova Southeastern University

71 total trials

What the Registry Record Tells You About NCT06269614

The ClinicalTrials.gov registry entry for NCT06269614 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (44% lower). The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Probiotic is the first listed.

NCT06269614 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06269614 about?

NCT06269614 is a clinical study titled "Assessing the Gut Microbiome and Its Association With Pediatric Stress and Cognition". Using a metabolomics approach in combination with eye-tracking data, this research study proposes to gather evidence from two interrelated body systems (gut and brain) in order to assess how the microbiome is involved in stress modulated symptoms in children with autism and children exposed to repea...

What is the current status of trial NCT06269614?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2023-01-12. Estimated completion is 2027-12-31.

What conditions does trial NCT06269614 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Adverse Childhood Experiences, Stress Reaction.

What interventions are being tested in trial NCT06269614?

The interventions under investigation include: Probiotic (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06269614?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06269614 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.